LIFEVANTAGE CORP Amortization of Other Deferred Charges
LIFEVANTAGE CORP (LFVN) reported Amortization of Other Deferred Charges of $583.74 thousand for the 9-month period ending 2011-03-31, per its 10-Q filed 2012-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAmortizationOfDeferredCharges · last filed 2012-05-15
- LIFEVANTAGE CORP amortization of other deferred charges for the quarter ending 2011-03-31 was $133.39K.
| Period end | Amortization of Other Deferred Charges 3 month | Amortization of Other Deferred Charges 6 month | Amortization of Other Deferred Charges 9 month |
|---|---|---|---|
| 2011-03-31 | $133.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | $583.74K 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $450.35K 10-Q · filed 2012-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |